Gallbladder cancer: Adjuvant and palliative treatment during Covid-19 pandemic in India

被引：0
作者：
Patel, Amol [1 ]
Batra, Atul [2 ]
Mehta, Prashant [3 ]
Sharma, Atul [2 ]
Sirohi, Bhawna [4 ]
Biswas, Bivas [5 ]
Gangulay, Sandip [5 ]
Gupta, Vineet Govinda [6 ]
机构：
[1] Army Hosp Res & Referral, Malignant Dis Treatment Ctr, Dept Med Oncol, New Delhi, India
[2] All India Inst Med Sci, Dr BRA IRCH, Dept Med Oncol, New Delhi, India
[3] Asian Inst Med Sci, Dept Med Oncol, Faridabad, Haryana, India
[4] Max Inst Canc Care, Dept Med Oncol, New Delhi, India
[5] Tata Med Ctr, Dept Med Oncol, Kolkata, W Bengal, India
[6] Artemis Hosp, Dept Med Oncol, Gurgaon, Haryana, India
来源：
INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY | 2020年 / 41卷 / 02期
关键词：
BILIARY-TRACT CANCER; PHASE-III; GEMCITABINE; OXALIPLATIN; CHEMOTHERAPY; CAPECITABINE; CISPLATIN; THERAPY;
D O I：
10.4103/ijmpo.ijmpo_110_20
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：132 / 134
页数：3
相关论文
共 12 条
  • [1] Randomized clinical trial of adjuvant gemcitabine chemotherapy versus observation in resected bile duct cancer
    Ebata, T.
    Hirano, S.
    Konishi, M.
    Uesaka, K.
    Tsuchiya, Y.
    Ohtsuka, M.
    Kaneoka, Y.
    Yamamoto, M.
    Ambo, Y.
    Shimizu, Y.
    Ozawa, F.
    Fukutomi, A.
    Ando, M.
    Nimura, Y.
    Nagino, M.
    [J]. BRITISH JOURNAL OF SURGERY, 2018, 105 (03) : 192 - 202
  • [2] Gemcitabine and Oxaliplatin Chemotherapy or Surveillance in Resected Biliary Tract Cancer (PRODIGE 12-ACCORD 18-UNICANCER GI): A Randomized Phase III Study
    Edeline, Julien
    Benabdelghani, Meher
    Bertaut, Aurelie
    Watelet, Jerome
    Hammel, Pascal
    Joly, Jean-Paul
    Boudjema, Karim
    Fartoux, Laetitia
    Bouhier-Leporrier, Karine
    Jouve, Jean-Louis
    Faroux, Roger
    Guerin-Meyer, Veronique
    Kurtz, Jean-Emmanuel
    Assenat, Eric
    Seitz, Jean-Francois
    Baumgaertner, Isabelle
    Tougeron, David
    de la Fouchardiere, Christelle
    Lombard-Bohas, Catherine
    Boucher, Eveline
    Stanbury, Trevor
    Louvet, Christophe
    Malka, David
    Phelip, Jean-Marc
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (08) : 658 - +
  • [3] Cisplatin/gemcitabine or oxaliplatin/gemcitabine in the treatment of advanced biliary tract cancer: a systematic review
    Fiteni, Frederic
    Nguyen, Thierry
    Vernerey, Dewi
    Paillard, Marie-Justine
    Kim, Stefano
    Demarchi, Martin
    Fein, Francine
    Borg, Christophe
    Bonnetain, Franck
    Pivot, Xavier
    [J]. CANCER MEDICINE, 2014, 3 (06): : 1502 - 1511
  • [4] Capecitabine plus oxaliplatin versus gemcitabine plus oxaliplatin as first-line therapy for advanced biliary tract cancers: a multicenter, open-label, randomized, phase III, noninferiority trial
    Kim, S. T.
    Kang, J. H.
    Lee, J.
    Lee, H. W.
    Oh, S. Y.
    Jang, J. S.
    Lee, M. A.
    Sohn, B. S.
    Yoon, S. Y.
    Choi, H. J.
    Hong, J. H.
    Kim, M. -J.
    Kim, S.
    Park, Y. S.
    Park, J. O.
    Lim, H. Y.
    [J]. ANNALS OF ONCOLOGY, 2019, 30 (05) : 788 - 795
  • [5] Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China
    Liang, Wenhua
    Guan, Weijie
    Chen, Ruchong
    Wang, Wei
    Li, Jianfu
    Xu, Ke
    Li, Caichen
    Ai, Qing
    Lu, Weixiang
    Liang, Hengrui
    Li, Shiyue
    He, Jianxing
    [J]. LANCET ONCOLOGY, 2020, 21 (03) : 335 - 337
  • [6] Cancer trends in Eastern India: Retrospective hospital-based cancer registry data analysis
    Pandey, Avinash
    Raj, Shraddha
    Madhawi, Richa
    Devi, Seema
    Singh, RajeshKumar
    [J]. SOUTH ASIAN JOURNAL OF CANCER, 2019, 8 (04) : 215 - +
  • [7] Oral capecitabine for the treatment of hepatocellular carcinoma, cholangiocarcinoma, and gallbladder carcinoma
    Patt, YZ
    Hassan, MM
    Aguayo, A
    Nooka, AK
    Lozano, RD
    Curley, SA
    Vauthey, JN
    Ellis, LM
    Schnirer, II
    Wolff, RA
    Charnsangavej, C
    Brown, TD
    [J]. CANCER, 2004, 101 (03) : 578 - 586
  • [8] Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study
    Primrose, John N.
    Fox, Richard P.
    Palmer, Daniel H.
    Malik, Hassan Z.
    Prasad, Raj
    Mirza, Darius
    Anthony, Alan
    Corrie, Pippa
    Falk, Stephen
    Finch-Jones, Meg
    Wasan, Harpreet
    Ross, Paul
    Wall, Lucy
    Wadsley, Jonathan
    Evans, Jeff T. R.
    Stocken, Deborah
    Praseedom, Raaj
    Ma, Yuk Ting
    Davidson, Brian
    Neoptolemos, John P.
    Iveson, Tim
    Raftery, James
    Zhu, Shihua
    Cunningham, David
    Garden, O. James
    Stubbs, Clive
    Valle, Juan W.
    Bridgewater, John
    [J]. LANCET ONCOLOGY, 2019, 20 (05) : 663 - 673
  • [9] Gemcitabine-cisplatin versus gemcitabine-oxaliplatin doublet chemotherapy in advanced gallbladder cancers: a match pair analysis
    Ramaswamy, Anant
    Ostwal, Vikas
    Pinninti, Rakesh
    Kannan, Sadhana
    Bhargava, Prabhat
    Nashikkar, Chaitali
    Mirani, Jimmy
    Banavali, Shripad
    [J]. JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 2017, 24 (05) : 262 - 267
  • [10] Modified gemcitabine and oxaliplatin or gemcitabine plus cisplatin in unresectable gallbladder cancer: Results of a phase III randomised controlled trial
    Sharma, Atul
    Mohanti, Bidhu Kalyan
    Chaudhary, Surendra Pal
    Sreenivas, V.
    Sahoo, Ranjit Kumar
    Shukla, Nootan Kumar
    Thulkar, Sanjay
    Pal, Sujoy
    Deo, Surya V.
    Pathy, Sushmita
    Dash, Nihar Ranjan
    Kumar, Sunil
    Bhatnagar, Sushma
    Kumar, Rakesh
    Mishra, Seema
    Sahni, Peush
    Iyer, Venkateswaran K.
    Raina, Vinod
    [J]. EUROPEAN JOURNAL OF CANCER, 2019, 123 : 162 - 170
12